No CrossRef data available.
Article contents
Myelin Oligodendrocyte Glycoprotein-Related Isolated Internuclear Ophthalmoplegia Mimicking Multiple Sclerosis
Published online by Cambridge University Press: 07 November 2023
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Keywords
- Type
- Letter to the Editor: New Observation
- Information
- Copyright
- © The Author(s), 2023. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation
References
Vosoughi, AR, Ling, J, Tam, KT, Blackwood, J, Micieli, JA. Ophthalmic manifestations of myelin oligodendrocyte glycoprotein-igG-associated disorder other than optic neuritis: a systematic review. Br J Ophthalmol. 2021;105:1591–8.CrossRefGoogle ScholarPubMed
Jarius, S, Kleiter, I, Ruprecht, K, in cooperation with the Neuromyelitis Optica Study Group (NEMOS),et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome. J Neuroinflammation. 2016;13:281.CrossRefGoogle ScholarPubMed
Vecchio, D, Virgilio, E, Naldi, P, Comi, C, Cantello, R. MOG-antibody demyelinating diseases: a case of post-partum severe rhombencephalitis and transverse myelitis. Mult Scler Relat Disord. 2018;21:9–10.CrossRefGoogle ScholarPubMed
Ambrosius, W, Michalak, S, Kozubski, W, Kalinowska, A. Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management. Int J Mol Sci. 2020;22:100.CrossRefGoogle ScholarPubMed
Stadelmann, C, Timmler, S, Barrantes-Freer, A, Simons, M. Myelin in the central nervous system: structure, function, and pathology. Physiol Rev. 2019;99:1381–431. DOI: 10.1152/physrev.00031.2018.CrossRefGoogle ScholarPubMed